Evidence map›Paper›PMID 34584461›Full record

ArticleClinical epidemiology2021

Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990-2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017.

Fang Wang, Yong Yu, Sumaira Mubarik, Yu Zhang, Xiaoxue Liu, Yao Cheng, Chuanhua Yu, Jinhong Cao

Registry-linked trialAbstract read
In one paragraph

Article in Clinical epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07039123 (Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population), which is not on this map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07039123 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population (PERSONAL)

TypeinterventionalSponsorUniversity of BernRan2025 to 2027Enrolled205ConditionsPrimary Prevention of Cardiovascular DiseaseArmsPolygenic Risk Score for Coronary Artery Disease (PRS-CAD), Standardized Risk Communication Tool (SCORE2)
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fang WangDepartment of epidemiology and biostatistics, School of Health Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0001-7687-2700
Yong YuComputer Teaching and Research Section, School of Public Health, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Sumaira MubarikDepartment of epidemiology and biostatistics, School of Health Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0001-6041-1061
Yu ZhangDepartment of Public Health, Medical College, Hubei Polytechnic University, Huangshi, Hubei, People's Republic of China.
Xiaoxue LiuDepartment of epidemiology and biostatistics, School of Health Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0002-1122-5745
Yao ChengObstetrics Department, Maternal and Child Health Care Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Chuanhua YuDepartment of epidemiology and biostatistics, School of Health Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0002-5467-2481
Jinhong CaoDepartment of epidemiology and biostatistics, School of Health Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID 0000-0002-0841-1491

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate the burden of ischemic heart disease (IHD) stratified by gender, age, geographic location, and social-demographic status for 21 regions across the world from 1990 to 2017.

methodsUsing the Global Burden of Disease Study (GBD) Results Tool, we extracted data on the incidence, mortality, disability-adjusted life years (DALYs), and age-standardized rates related to IHD, as IHD burden measures. Trend analyzes were conducted for major regions. Risk factors for DALYs (obtained from the GBD comparative risk assessment framework) were also analyzed.

resultsGlobally, 10.6 million (95% uncertainty interval [UI]: 9.6-11.8) cases of IHD occurred in 2017, with 8.9 million (95%UI:8.8-9.1) IHD-related deaths. Both the age-standardized incidence rate (ASIR) and death rate (ASDR) declined from 1990 to 2017 (percentage change: 27.4% and 30.0%, respectively), with average annual percent change (AAPC) values of -1.2% and -1.3%, respectively. In 2017, the global number of IHD-related DALYs was 170.3 million (95%UI:167.1-174.0), and the middle socio-demographic index (SDI) quintile contributed the most to these DALYs. In most regions, indicators (incidence, mortality, and DALYs) declined steadily with SDI increased. High systolic blood pressure (SBP) was the most significant contributor to the DALYs in most regions, accounting for 118.18 million DALYs in 2017 globally, followed by high low-density lipoprotein cholesterol and a diet low in nuts and seeds (101.78 and 52.86 million, respectively).

conclusionEven though the trend in IHD morbidity and mortality decreased globally, the IHD burden remains high, particularly in regions with lower SDI. It is necessary to learn successful and effective experience in controlling IHD risks and decreasing health disparities to reduce the IHD burden.

Indexed as

epidemiologyglobal burdenischemic heart diseaserisk factorstemporal trends

Identifiers

PMID34584461
PMCPMC8464307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.